Extending Market Exclusivity Periods
There is no excerpt because this is a protected post.
Categories: Drug Manufacturer Strategies for Keeping Drug Costs High
The Low Cost of Generic Tadalafil Prescription Medication
Main Information On Tadalafil Principle of Action Tadalafil is the main active ingredient of Cialis, one of the most popular drugs for erectile dysfunction (ED) today. This substance is responsible for the effect of Cialis on the male body. How is the effect of the drug achieved, which allows to improve potency and get rid...
National Online Survey of Seniors Regarding the Medicare Part D Prescription Drug Benefit
There is no excerpt because this is a protected post.
Categories: Uncategorized
Podcast: The Impact of COVID-19 on the Pharmaceutical Market
JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare – and human health – forward. JC Scott: Welcome to The Pharmacy Benefit, a podcast...
Categories: Podcast
Key Findings from Survey of Benefit Managers
Our national survey of benefit managers and human resources directors, conducted online June 4-9, 2020, consists of 250 respondents drawn from a list of benefit managers and human resources directors provided by Dynata. All respondents work for a company with 1,000 or more employees, have at least 1,000 individuals under coverage, and have an annual...
Categories: Research
Just the Facts: Pharmacy Direct and Indirect Remuneration Increases Value and Improves Quality
During the Energy and Commerce Health Subcommittee hearing on “The Fiscal Year 2021 HHS Budget and Oversight of the Coronavirus Outbreak” several inaccurate remarks were made on pharmacy direct and indirect remuneration (DIR). What is Pharmacy DIR? Pharmacy benefit managers (PBMs) and Part D plan sponsors use pharmacy DIR to create high-quality, value-based pharmacy networks,...
Categories: Press Releases
Response to XIL Consulting’s “Payers and PBMs Profit from Obscure Pharmacy Fees, While Seniors See No Relief in Prescription Costs”
A recent blog (“Payers and PBMs Profit from Obscure Pharmacy Fees, While Seniors See No Relief in Prescription Costs”) suggests performance-based price concessions are retained by PBMs, restrict the growth of independent pharmacies, and inflate Medicare Part D enrollee’s out-of-pocket costs—unfounded suggestions that evidence does not support.[1] Performance-based Pharmacy Reimbursement Saves Taxpayer Dollars and Helps Lower...
Categories: Uncategorized